Protocol for the development of versions of the Montreal Cognitive Assessment (MoCA) for people with hearing or vision impairment
Piers Dawes(The University of Queensland), Iracema Leroi(Trinity College Dublin), Ziad Nasreddine(Université de Sherbrooke), Saima Sheikh(Imperial College London), Chyrssoula Thodi(European University Cyprus), Wai Kent Yeung(University of Manchester), Anna Pavlina Charalambous(European University Cyprus), David Reeves(Manchester Academic Health Science Centre), Kathleen Gallant, Annie Pye(Manchester Academic Health Science Centre)
Cited by 71
Related Papers
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
|The Lancet Neurology|2009|460
Cognitive Impairment in Parkinson Disease
|Journal of Geriatric Psychiatry and Neurology|2012|380
Psychometrics of the Montreal Cognitive Assessment (MoCA) and its subscales: validation of the Taiwanese version of the MoCA and an item response theory analysis
|International Psychogeriatrics|2011|277
Randomized placebo‐controlled trial of donepezil in cognitive impairment in Parkinson's disease
|International Journal of Geriatric Psychiatry|2004|228
Neuropsychiatry of Huntington’s Disease and Other Basal Ganglia Disorders
|Psychosomatics|2000|223